Original Research Article
Weight, Blood Pressure, Osmolarity, and Glucose Levels across Various Stages of Alzheimer's Disease and Vascular DementiaHogan D.B.a,b · Ebly E.M.a · Rockwood K.c
Departments of aClinical Neurosciences and bMedicine, University of Calgary, Calgary, and cDivision of Geriatric Medicine, Dalhousie University, Halifax, Canada
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Data collected as part of the Canadian Study of Health and Aging were analyzed to determine whether physiological changes associated with Alzheimer''s disease are common to other types of dementia and are related more to the severity of cognitive impairment. We found that blood pressure and body mass index decreased with increasing dementia severity in both probable Alzheimer''s disease and vascular dementia. There were no differences in mean random blood glucose levels or serum osmolalities between types or stages of dementia. We conclude that certain ‘hypometabolic’ features are associated with dementia severity and are not unique to Alzheimer''s disease.
© 1997 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.